GoodRx Holdings Inc (NASDAQ: GDRX)’s stock price has increased by 7.85 compared to its previous closing price of 4.11. However, the company has seen a 12.50% increase in its stock price over the last five trading sessions. businesswire.com reported 2025-06-10 that SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription service for erectile dysfunction (ED). Designed to meet consumers where they are and remove common barriers such as high costs, long wait times, and inconvenience, this all-in-one solution offers a fast, discreet, and affordable option for ED treatment. A new report from GoodRx reveals a clear gap in care: nearly 1 in 3 U.S. men.
Is It Worth Investing in GoodRx Holdings Inc (NASDAQ: GDRX) Right Now?
GoodRx Holdings Inc (NASDAQ: GDRX) has a higher price-to-earnings ratio of 59.66x compared to its average ratio. GDRX has 36-month beta value of 1.17. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 1 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for GDRX is 83.18M, and currently, short sellers hold a 5.10% ratio of that float. The average trading volume of GDRX on June 10, 2025 was 1.46M shares.
GDRX’s Market Performance
GDRX stock saw an increase of 12.50% in the past week, with a monthly gain of 2.61% and a quarterly increase of -2.79%. The volatility ratio for the week is 3.49%, and the volatility levels for the last 30 days are 2.73% for GoodRx Holdings Inc (GDRX). The simple moving average for the last 20 days is 11.13% for GDRX stock, with a simple moving average of -15.25% for the last 200 days.
Analysts’ Opinion of GDRX
Many brokerage firms have already submitted their reports for GDRX stocks, with Mizuho repeating the rating for GDRX by listing it as a “Neutral.” The predicted price for GDRX in the upcoming period, according to Mizuho is $5 based on the research report published on December 04, 2024 of the previous year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see GDRX reach a price target of $10. The rating they have provided for GDRX stocks is “Strong Buy” according to the report published on August 09th, 2024.
RBC Capital Mkts gave a rating of “Outperform” to GDRX, setting the target price at $10 in the report published on May 23rd of the previous year.
GDRX Trading at 4.13% from the 50-Day Moving Average
After a stumble in the market that brought GDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -52.13% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at GDRX starting from Spectrum Equity VII, L.P., who sale 10,677 shares at the price of $4.09 back on Jun 06 ’25. After this action, Spectrum Equity VII, L.P. now owns 0 shares of GoodRx Holdings Inc, valued at $43,706 using the latest closing price.
Spectrum VII Investment Manage, the Affiliate of GoodRx Holdings Inc, proposed sale 6,828 shares at $4.00 during a trade that took place back on Jun 06 ’25, which means that Spectrum VII Investment Manage is holding shares at $27,312 based on the most recent closing price.
Stock Fundamentals for GDRX
Current profitability levels for the company are sitting at:
- 0.1 for the present operating margin
- 0.92 for the gross margin
The net margin for GoodRx Holdings Inc stands at 0.06. The total capital return value is set at 0.07. Equity return is now at value 4.43, with 2.07 for asset returns.
Based on GoodRx Holdings Inc (GDRX), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 2.72. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is 2.99.
Currently, EBITDA for the company is 153.92 million with net debt to EBITDA at -1.71. When we switch over and look at the enterprise to sales, we see a ratio of 1.69. The receivables turnover for the company is 4.98for trailing twelve months and the total asset turnover is 0.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.23.
Conclusion
To put it simply, GoodRx Holdings Inc (GDRX) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
